XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.25.1

Segment Information (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2025
Segment Reporting [Abstract] |
Schedule of Net Sales and Operating Profit by Segment | The Company’s net sales, significant segment expenses and operating profit, by reportable segment were:
| Three Months Ended March 31, 2025
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 998 |  |  | $ | 377 |  |  | $ | 415 |  |  | $ | 10 |  |  | $ | 196 |
Latin America | 1,143 |  |  | 487 |  |  | 316 |  |  | (7) |  |  | 348 |
Europe | 690 |  |  | 258 |  |  | 254 |  |  | 7 |  |  | 172 |
Asia Pacific | 690 |  |  | 261 |  |  | 239 |  |  | (7) |  |  | 198 |
Africa/Eurasia | 271 |  |  | 104 |  |  | 106 |  |  | 4 |  |  | 57 |
Total Oral, Personal and Home Care | 3,792 |  |  |  |  |  |  |  |  | 971 |
Pet Nutrition | 1,118 |  |  | 437 |  |  | 422 |  |  | 1 |  |  | 258 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (153) |
Total | $ | 4,911 |  |  |  |  |  |  |  |  | $ | 1,076 |
Note: Table may not sum due to rounding. (1)Other (income) expense, net primarily includes amortization of intangible assets and equity income.
| Three Months Ended March 31, 2024
| Net sales |  | Cost of Sales |  | Selling, general and administrative expenses |  | Other (income) expense, net (1) |  | Operating Profit
Reportable Segments |  |  |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |  |  |
North America | $ | 1,035 |  |  | $ | 390 |  |  | $ | 419 |  |  | $ | 13 |  |  | $ | 214 |
Latin America | 1,253 |  |  | 502 |  |  | 345 |  |  | 1 |  |  | 405 |
Europe | 673 |  |  | 267 |  |  | 245 |  |  | 8 |  |  | 153 |
Asia Pacific | 727 |  |  | 284 |  |  | 242 |  |  | (7) |  |  | 207 |
Africa/Eurasia | 276 |  |  | 106 |  |  | 99 |  |  | 5 |  |  | 66 |
Total Oral, Personal and Home Care | 3,963 |  |  |  |  |  |  |  |  | 1,044 |
Pet Nutrition | 1,102 |  |  | 482 |  |  | 413 |  |  | 9 |  |  | 199 |
Reconciliation with Total Company Operating Profit |  |  |  |  |  |  |  |  |
Corporate |  |  |  |  |  |  |  |  | (196) |
Total | $ | 5,065 |  |  |  |  |  |  |  |  | $ | 1,047 |
Note: Table may not sum due to rounding. (1)Other (income) expense, net primarily includes amortization of intangible assets and equity income. The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
| Three Months Ended |  |
| March 31, |  |
| 2025 |  | 2024 |  |  |  |
Net sales |  |  |  |  |  |  |
Oral Care | 44 | % |  | 43 | % |  |  |  |
Personal Care | 17 | % |  | 18 | % |  |  |  |
Home Care | 16 | % |  | 17 | % |  |  |  |
Pet Nutrition | 23 | % |  | 22 | % |  |  |  |
Total Net sales | 100 | % |  | 100 | % |  |  |  |
Capital expenditures and depreciation and amortization expense by segment were:
| Three Months Ended |  |
| March 31, |  |
| 2025 |  | 2024 |  |  |  |
Capital expenditures |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |
North America | $ | 17 |  |  | $ | 8 |  |  |  |  |
Latin America | 28 |  |  | 21 |  |  |  |  |
Europe | 8 |  |  | 8 |  |  |  |  |
Asia Pacific | 13 |  |  | 9 |  |  |  |  |
Africa/Eurasia | 2 |  |  | 1 |  |  |  |  |
Total Oral, Personal and Home Care | 68 |  |  | 47 |  |  |  |  |
Pet Nutrition | 21 |  |  | 53 |  |  |  |  |
Corporate | 35 |  |  | 26 |  |  |  |  |
Total Capital expenditures | $ | 124 |  |  | $ | 126 |  |  |  |  |
| Three Months Ended |  |
| March 31, |  |
| 2025 |  | 2024 |  |  |  |
Depreciation and amortization |  |  |  |  |  |  |
Oral, Personal and Home Care |  |  |  |  |  |  |
North America | $ | 30 |  |  | $ | 31 |  |  |  |  |
Latin America | 24 |  |  | 27 |  |  |  |  |
Europe | 15 |  |  | 16 |  |  |  |  |
Asia Pacific | 20 |  |  | 20 |  |  |  |  |
Africa/Eurasia | 2 |  |  | 2 |  |  |  |  |
Total Oral, Personal and Home Care | 92 |  |  | 96 |  |  |  |  |
Pet Nutrition | 31 |  |  | 30 |  |  |  |  |
Corporate | 25 |  |  | 24 |  |  |  |  |
Total Depreciation and amortization | $ | 148 |  |  | $ | 150 |  |  |  |  |
Note: Table may not sum due to rounding.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration